Duloxetine: all 274 studies that test it

Page 3 of 3. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.

• Comparison of the Efficacy of Duloxetine With Placebo in Patients With Chronic Low Back Pain With a Radicular ComponentCompletedNCT01166048Phase 4
• Study to Assess Mechanisms in Peripheral Tissue Innervation for FibromyalgiaCompletedNCT01127490Not applicable
• Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or PregabalinWithdrawnNCT01116531Phase 4
• A Study for Adolescents With Fibromyalgia SyndromeWithdrawnNCT01089621Phase 4
• Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk GenotypeStatus unknownNCT01078870Phase 4
• Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)CompletedNCT00990067Phase 1
• Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)CompletedNCT00940693Phase 2
• A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy SubjectsCompletedNCT00933452Phase 1
• Assessment of Cognitive Functioning Before and After Treatment With DuloxetineCompletedNCT00933439Not applicable
• Duloxetine for Major Depression in Peri-/Postmenopausal WomenStatus unknownNCT00889369Phase 4
• Effects of Duloxetine on Fear Conditioning in Posttraumatic Stress Disorder (PTSD)CompletedNCT00763178Early Phase 1
• The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory ControlCompletedNCT00660751Not applicable
• Cymbalta for Depression as a Complication of BereavementStatus unknownNCT00658931Phase 4
• Duloxetine for the Treatment of Postpartum DepressionWithdrawnNCT00617045Not applicable
• A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis PainCompletedNCT00609557Phase 4
• Getting Biased Treatment Study: How Psychotherapy and Antidepressants Change Brain Activity in Chronic DepressionStatus unknownNCT00596986Not applicable
• Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress DisorderStatus unknownNCT00583193Phase 3
• Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+CompletedNCT00552682Phase 3
• Duloxetine - Warfarin Pharmacodynamic StudyCompletedNCT00533026Phase 1
• An Open Trial of Duloxetine on Comorbid Major Depression and Chronic HeadacheCompletedNCT00531895Phase 4
• Duloxetine for Perimenopausal DepressionCompletedNCT00517985Phase 4
• Duloxetine Versus Duloxetine Plus Non-Drug Therapy for DepressionCompletedNCT00494377Phase 4
• Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI StudyTerminatedNCT00491348Not applicable
• Duloxetine Versus Paroxetine for Major DepressionCompletedNCT00489775Phase 3
• Duloxetine Versus Placebo for FibromyalgiaCompletedNCT00489073Phase 3
• Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)CompletedNCT00479726Phase 4
• Duloxetine vs Placebo in the Treatment of General AnxietyCompletedNCT00475969Phase 3
• Urge Incontinence Bladder Overactivity StudyCompletedNCT00475696Phase 2
• Duloxetine Stress Urinary Incontinence Efficacy and Safety StudyCompletedNCT00475397Phase 3
• Efficacy and Safety Stress Urinary Incontinence StudyCompletedNCT00475358Phase 3
• Open Label Study of Duloxetine for the Treatment of Phantom Limb PainTerminatedNCT00425230Not applicable
• Evaluation of the Effects of Duloxetine on NorepinephrineCompletedNCT00414323Phase 1
• Treatment With Duloxetine for OCD PatientsWithdrawnNCT00399022Not applicable
• A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy VolunteersCompletedNCT00387413Phase 1
• Effects of Pregabalin, Duloxetine & Amitriptyline on Pain & SleepCompletedNCT00370656Phase 2/3
• Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00366652Phase 3
• A Pilot Study Assessing Duloxetine's Efficacy in Atypical DepressionCompletedNCT00296699Phase 4
• Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve PainCompletedNCT00266643Phase 4
• To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence SymptomsCompletedNCT00244296Phase 4
• Duloxetine Versus Placebo in the Treatment of FMSCompletedNCT00233025Phase 3
• Treatment of MDEs During the Course of Psychotic Disorders With DuloxetineCompletedNCT00224302Phase 4
• Switching to Duloxetine From Other AntidepressantsCompletedNCT00191932Phase 4
• A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and PainCompletedNCT00191919Phase 3
• Duloxetine in the Treatment of Melancholic DepressionCompletedNCT00191685Phase 3
• Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine TrialsCompletedNCT00191594Phase 3
• Open Label Phase III Duloxetine Study for Stress Urinary IncontinenceCompletedNCT00191204Phase 3
• Duloxetine in the Treatment of Stress Urinary Incontinence.CompletedNCT00191087Phase 3
• A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive DisorderCompletedNCT00191061Phase 4
• Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary IncontinenceCompletedNCT00190996Phase 3
• Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.CompletedNCT00190905Phase 4
• Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia SyndromeCompletedNCT00190866Phase 3
• Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress IncontinenceCompletedNCT00190853Phase 3
• Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)CompletedNCT00190827Phase 3
• Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.CompletedNCT00190814Phase 3
• To Evaluate the Safety of Duloxetine in Patients With Stress Urinary IncontinenceCompletedNCT00190645Phase 3
• To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary IncontinenceCompletedNCT00190632Phase 3
• Efficacy and Safety of DuloxetineCompletedNCT00190619Phase 3
• Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary IncontinenceCompletedNCT00190606Phase 2
• Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress IncontinenceCompletedNCT00190567Phase 2
• Duloxetine for the Treatment of DysthymiaCompletedNCT00185575Not applicable
• A Study of Duloxetine in the Treatment of FibromyalgiaCompletedNCT00125892Phase 3
• Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety DisorderCompletedNCT00122863Phase 3
• A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00122850Phase 3
• A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00122837Phase 3
• Duloxetine Compared With Placebo in Patients With Generalized Anxiety DisorderCompletedNCT00122824Phase 3
• Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With DepressionCompletedNCT00073411Phase 3
• Duloxetine vs. Active Comparator in the Treatment of Patients With DepressionCompletedNCT00071695Phase 4
• Duloxetine vs. Active Comparator for the Treatment of DepressionCompletedNCT00067912Phase 4
• Study of Duloxetine in Elderly Patients With Major Depressive DisorderCompletedNCT00062673Phase 3
• A Study for the Treatment of Painful Diabetic NeuropathyCompletedNCT00058968Phase 3
• Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major DepressionCompletedNCT00042575Phase 3
• Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major DepressionCompletedNCT00042562Phase 3
• Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and PainCompletedNCT00036335Phase 3
• Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive DisorderCompletedNCT00036309Phase 3

← Duloxetine overview